NANBIOSIS attended a University of Zaragoza course on digital disinformation, cybersecurity and EU regulation, reinforcing its commitment to trusted scientific communication.
Jaca, July 2026 — From 13 to 15 July 2026, NANBIOSIS attended the course “Disinformation and Digital Protection in Europe: Informational, Business, Reputational, Economic, Technological and Social Challenges”, held at the University of Zaragoza. Representing NANBIOSIS, Gabriel Alfranca participated as an attendee in this multidisciplinary training programme dedicated to understanding one of the most pressing challenges facing today’s digital society.
Coordinated by David Corral Hernández, Head of International Relations and Cooperation at RTVE Madrid, and Ana Mancho de la Iglesia, Professor at the University of Zaragoza and Director of the Reporterismo 360º Master’s Programme (University of Zaragoza–RTVE), the course brought together experts from academia, European institutions, public media, cybersecurity, strategic communications and industry.
Over three days, participants explored the mechanisms behind digital disinformation and coordinated influence campaigns, the impact of cyberattacks and phishing on organisations, the role of algorithms and online platforms, and the growing use of artificial intelligence to generate misleading content, including deepfakes. The programme also addressed European regulatory frameworks such as the Digital Services Act (DSA) and data protection legislation, alongside media verification, editorial responsibility and crisis communication strategies.
Sessions featured contributions from specialists representing the European Parliament, RTVE, Vodafone Business, Ibercaja, cybersecurity and national security experts, as well as academics with expertise in communication, journalism and digital resilience.
The course was closed down by Begoña Pérez Calle, Professor at Universidad de Zaragoza and Delegate of the Rector for Extraordinary Courses.
For NANBIOSIS, participation in this course reinforces its commitment to responsible scientific communication, digital resilience and the protection of institutional reputation. As a national research infrastructure supporting biomedical research and innovation, maintaining high standards of trustworthy communication and understanding emerging digital risks are increasingly important for engaging with researchers, industry, policymakers and society.
By keeping abreast of evolving challenges in digital information, cybersecurity and European policy, NANBIOSIS continues to strengthen its capacity to communicate science accurately and transparently while supporting a trustworthy research and innovation ecosystem.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
